We have mapped a cellular senescence gene, SEN16, within a genetic distance of 3 ± 7 cM, at 16q24.3. Microcell mediated transfer of a normal human chromosome 16, 16q22-qter or 16q23-qter restored cellular senescence in four immortal cell lines, derived from human and rat mammary tumors. The resumption of inde®nite cell proliferation, concordant with the segregation of the donor chromosome, con®rmed the presence of a senescence gene at 16q23-qter. While microcell hybrids were maintained in selection medium to retain the donor chromosome, sporadic immortal revertant clones arose among senescent cells. Reversion to immortal growth could occur due to inactivation of the senescence gene either by a mutation or a deletion. The analysis for chromosome 16 speci®c DNA markers, in revertant clones of senescent microcell hybrids, revealed a consensus deletion, spanning a genetic interval of approximately 3 ± 7 cM at 16q24.3.
Introduction
Normal diploid mammalian cells undergo replicative senescence after a ®nite number of population doublings (Hay¯ick and Moorehead, 1961; Hay¯ick, 1965) . In contrast, cells cultured from many tumors can either proliferate inde®nitely or have an increased proliferative lifespan (Stamps et al., 1992) . Senescent cells are incapable of DNA replication but remain metabolically active for an extended period of time and are resistant to apoptosis (Goldstein, 1990; Wang, 1995) . Cellular senescence is a genetically programmed process, expressed as a dominant phenotype over inde®nite proliferation in hybrids between normal and immortal cells (Bunn and Tarrant, 1980; Pereira-Smith and Smith, 1983) . By somatic cell hybrid analysis among a large number of immortal cell lines of diverse origin, four complementation groups have been identi®ed for inde®nite proliferation (Pereira-Smith and Smith, 1988) .
Spontaneous immortalization can occur in cultured rodent cells (Barrett and Ts'o, 1978) but has not been observed in human cells. Transformation of normal human cells with oncogenic DNA viruses extends the proliferative lifespan, but such cells eventually enter a state of irreversible growth arrest (Gotoh et al., 1979; Neu®eld et al., 1987) . However, human cells transformed with oncogenic DNA viruses can give rise to immortal clones at a low frequency (Huschtscha and Holliday, 1983; Neu®eld et al., 1987; Shay and Wright, 1989) . The immortalization of cells following transformation with DNA viruses has been shown to involve alterations in the cell genome (Neu®eld et al., 1987; Goolsby et al., 1991; Hubbard-Smith et al., 1992; Steenbergen et al., 1998) . Thus, acquisition of inde®nite proliferation is a multistep process and requires inactivation of cellular genes in addition to the function of proteins encoded by the viral genome (Shay et al., 1991; Hubbard-Smith et al., 1992) .
Cellular senescence has been postulated as a mechanism of tumor suppression, and immortalization appears to be an important step in tumor progression (O'Brien et al., 1986; Sager, 1989; Yeager et al., 1998) . Suggestive evidence for the role of senescence in protection against tumorigenesis comes from the comparison of normal and pre-neoplastic immortal mammary epithelial cells, transplanted into cleared mammary fat pads (Daniel et al., 1983) . The proliferation of normal mammary cells declines after 5 ± 6 serial passages ending in a state of senescence, whereas pre-neoplastic immortal cells can be passaged inde®nitely and eventually give rise to neoplastic growth (reviewed in Medina, 1996; Daniel et al., 1983; Medina et al., 1993) . Similarly, in vitro cultures of myoinvasive transitional cell carcinomas (TCC) of bladder give rise to immortal cell lines, while super®cial non-invasive TCC cells, like normal human uroepithelial cells, undergo senescence after a limited number of population doublings (Yeager et al., 1997) . These studies suggest that escape from senescence is essential for neoplastic expansion and may accelerate tumor progression by increasing the opportunity for additional mutations in proliferating cell populations.
Functional complementation by microcell mediated chromosome transfer into tumor cells has been used to identify chromosomes carrying genes which suppress in vitro cell growth (reviewed in Stanbridge, 1992) , tumorigenicity and/or metastasis in nude mice (Goyette et al., 1992; Negrini et al., 1994; Welch et al., 1994) or restore cellular senescence (reviewed in Oshimura and Barrett, 1997) . Using this approach, putative cell senescence genes have been identi®ed on chromosomes 1, 2, 3, 4, 6, 7, 17, 18 and X (Hensler et al., 1994; Uejima et al., 1995; Rimessi et al., 1994; Ning et al., 1991; Gualandi et al., 1994; Sandhu et al., 1994 Sandhu et al., , 1996 Ogata et al., 1993; Yamada et al., 1990; Wang et al., 1992 ; and our unpublished results). Conceptually these studies imply that a single gene, present on a donor chromosome, confers senescence in recipient cells. Reversion to inde®nite proliferation can occur due to inactivation of this gene by mutation or deletion of the senescence gene (Sandhu et al., 1996) . In this paper we report the identi®cation of a gene (SEN16) on chromosome 16 that restores senescence in human and rat mammary tumor cells. We have applied a deletion mapping approach to de®ne the position of the gene within a genetic interval of 3 ± 7 cM at 16q24.3.
Results

Chromosome transfer into tumor cell lines
Normal human chromosomes 7, 13 or 16 as well as chromosome fragments 16q22-qter or 16q23-qter, each tagged with gpt, were transferred individually into human and rat mammary tumor cell lines via microcell fusion. Microcell hybrids were recovered in MX selection medium with an average frequency of 1 per 10 6 recipient cells. Period from the time a colony was observed to the detachment of cells from the plate was used as an objective endpoint of colony survival Chromosome transfer colonies were maintained in MX medium and examined at regular intervals to assess colony and cell morphology and growth characteristics. Based on these criteria, microcell hybrid clones fell into two distinct classes: (1) Immortal colonies were indistinguishable from the parental tumor cells, which proliferate inde®nitely with a doubling time of 15 ± 30 h; (2) Senescent colonies consisted of enlarged¯attened vacuolated cells, with an initial doubling time of 72 ± 96 h that increased progressively until complete growth arrest after 6 ± 8 weeks (Table 1 and Figure 1 ). At this stage, each senescent colony contained between 500 and 2000 cells which remained attached to the surface in a nondividing state for an additional 1 ± 2 months.
Following the transfer of chromosome 16, 16q22-qter or 16q23-qter, a total of 56 independent microcell hybrid colonies were obtained in two human breast tumor cell lines (MCF.7 and SKBR-3), while 99 colonies were recovered in two rat mammary tumor cell lines (NMU and LA7) ( Table 1 ). All microcell hybrid clones carrying chromosome 16, 16q22-qter or 16q23-qter displayed the senescent phenotype (Table 1 and Figure 1 ). In contrast, the introduction of chromosome 7 into LA7 or chromosome 13 into MCF.7 and NMU cells did not aect the morphology or proliferation potential of the recipient cell lines (Table 1 and Figure 1 ). These results show that chromosome 16 carries a gene, located in the region 16q23-qter, that induces senescence in human as well as in rat mammary tumor cells.
Analysis for the presence of donor chromosome in senescent microcell hybrids DNA prepared from senescent chromosome transfer clones was analysed by PCR for the presence of chromosome 16 speci®c markers, in parallel with DNA from donor and recipient cells. Since donor chromosomes are tagged with gpt, retention of gpt in all microcell hybrids was con®rmed by PCR ( Figure 2a ). Microcell hybrids of MCF.7 and SKBR-3 cells were examined for the presence of donor chromosome 16 alleles for 15 polymorphic microsatellite (CA) n repeat markers, while colonies of rat cells were analysed for 89 markers. A typical example of this type of analysis is presented in Figure 2 and a list of the markers is given in Material and methods. These experiments con®rmed that senescent microcell hybrids retained all donor chromosome markers. The presence of the donor chromosome in microcell hybrids of rat cells was also con®rmed by cytogenetic analysis by FISH ( Figure 3 ).
Reversion to inde®nite proliferation concordant with the segregation of donor chromosome
If the donor chromosome is indeed responsible for cell senescence in chromosome transfer clones, its loss should result in reversion to inde®nite proliferation. Cells from pre-senescent microcell hybrid colonies were cultured in non-selective medium to permit loss of the donor chromosome by random segregation. Independent immortal segregant clones, which arose in presenescent cell populations, were isolated individually for each recipient cell line. Segregant clones were examined for the presence of gpt and chromosome 16 speci®c markers. This analysis revealed that segregant clones no longer contained the donor human chromosome (data not shown). Reversion to immortal growth, concordant with loss of the donor human chromosome, con®rmed that the restoration of senescence in tumor cells requires the retention of donor chromosome 16, 16q22-qter or 16q23-qter.
Localization of the senescence gene within a 3 ± 7 cM genetic interval at 16q24.3
While senescent microcell hybrid colonies were maintained in MX medium, fast growing parental type immortal revertant clones appeared spontaneously in senescent cell populations. Such revertants, which retained the gpt tag and most of the donor chromosome, must result from inactivation of the senescence gene through mutation or deletion. We isolated 5 and 16 independent MX revertant clones from microcell hybrids of human and rat cells, respectively, containing chromosome 16, 16q22-qter or 16q23-qter.
To facilitate high resolution mapping of the senescence gene, all MX revertant clones were tested by PCR for markers mapped to the region 16q22-qter. As expected, all revertant clones retained the gpt tag. Of the 16 rat revertant clones, 13 (represented by Rev 1 in Figure 4 ) retained all 89 markers tested but three revertants Rev 2, 3 and 4 (Figure 4 ) each lost a block of contiguous linked markers. Figure 2 shows representative PCR analysis of four markers which are deleted in Rev 2, 3 and 4, and Figure 4 summarizes the results from 36 markers located at 16q24.2-16q24.3. MX revertants like Rev 1 which retained all the markers may carry point mutations or small deletions in the senescence gene, not detectable with the available set of markers. While the size of the deletion varied among Rev 2, 3 and 4, they all shared a consensus deletion of a set of 21 contiguous markers (Figure 4) . The consensus deletion is¯anked by markers D16S486 and D16S413 (Figure 4 ). According to the latest integrated map of chromosome 16 in genetic databases, D16S486 and D16S413 are separated by a genetic distance of less than 7 cM at 16q24.3 (NCBI database; Doggett et al., 1995; Kozman et al., 1995; Dib et al., 1996) . However, all 21 markers located in the consensus deletion are mapped within a span of 3 cM (Figure 4) . These results show that SEN16 is located within a 3 ± 7 cM genetic interval at 16q24.3.
High resolution mapping of MX revertants of microcell hybrids of MCF.7 and SKBR-3 cells was hindered by the lack of polymorphism between recipient and donor alleles of most available markers. Of the markers listed in Figure 4 , only D16S498 and D16S413 were found to be polymorphic between donor and recipient chromosomes. Both of these markers were consistently deleted in all ®ve revertant clones derived from senescent microcell hybrids of MCF.7 and SKBR-3 cells. D16S498 is part of the consensus deletion observed in rat revertant clones, while D16S413 is located just outside the consensus deletion (Figure 4) . Thus the available data from microcell hybrids of human breast tumor cells are consistent with the mapping data in rat revertants and support the hypothesis that the same gene restores senescence in all four cell lines. To strengthen this conclusion, a derivative of chromosome 16q23-qter, carrying the mapped deletion in Rev 4, was introduced into MCF.7 cells. As expected, all four microcell hybrids obtained in this experiment were identical to the MCF.7 immortal parental tumor cells (data not shown). These results con®rmed that the deletion mapped in Rev 4 abolishes the ability of 16q23-qter to restore senescence in human tumor cells. 
Discussion
We have mapped a cell senescence gene, SEN16, within a genetic interval of 3 ± 7 cM at 16q24.3. The introduction and retention of a normal human chromosome 16, 16q22-qter or 16q23-qter into immortal mammary tumor cell lines restores cellular and colony morphology similar to normal breast epithelial cells and induces progressive retardation of proliferation leading to complete growth arrest. Recipient tumor cells carrying donor chromosome 16 are able to undergo 10 ± 15 doublings before entering growth arrest. This residual growth potential allows sucient expansion of chromosome transfer clones to identify viable senescent colonies, to extract DNA for analysis, to observe segregation of the donor chromosome in non-selective medium, and to isolate revertant clones in selective medium. Resumption of inde®nite proliferation, concordant with the segregation of the donor chromosome, con®rmed that restoration of senescence depends on retention of the donor chromosome. In control experiments, human chromosomes 7 or 13 had no eect on the proliferation of same cells.
In the course of these studies, we also developed an eective general strategy for the mapping of cell senescence/tumor suppressor genes. This strategy is based upon the identi®cation of the smallest consensus deletion in the donor chromosome in independent revertant clones that arise in senescent microcell hybrids maintained in the selection medium. In the present study, the shortest shared consensus deletion that abolishes senescence gene activity is¯anked by the markers, D16S486 and D16S413 which are separated by a genetic interval of less than 7 cM at 16q24.3 (NCBI database). However, markers located in the consensus deletion are mapped within a genetic interval of 3 cM at 16q24.3. A majority of the markers located in the consensus deletion are carried in two overlapping Yeast Arti®cial Chromosome (YAC) clones comprised of approximately 700 kb of DNA (our unpublished results). One of these YACs restores senescence when introduced into same tumor cell lines, con®rming that SEN16 is located within the consensus deletion (manuscript in preparation).
The parallel use of rat and human cells as recipients was critical to the success of our mapping strategy. Heterospeci®c human/rat transfers made it easy to track human donor DNA markers, permitting highresolution mapping which was not possible in human intraspecies hybrids, where only polymorphic markers can be used to map the donor chromosome. However, parallel low-resolution mapping in human cells and the transfer of a derivative of 16q23-qter from a rat revertant into human cells, served to con®rm that the same gene is active in human as well as in rat recipient cells. Interestingly, SEN16 functions equally well in human and rat mammary tumor cells but does not restore senescence in mouse A9 cells, the host cell line of the mouse/human monochromosomal hybrid donor for chromosome 16.
Mapping of SEN16 was also facilitated by the identi®cation and use of subchromosomal fragments of chromosome 16, which greatly reduced the number of markers required for deletion mapping. Both 16q22-qter and 16q23-qter, present in the respective mouse/ human monochromosomal hybrid donor cell lines, are translocated onto mouse chromosomes, which are presumably transferred and retained along with the gpt tagged human fragments in the recipient tumor cell lines. Although the mouse carrier chromosomes have not been characterized, they are most likely dierent in the two subchromosomal hybrid cell lines which were generated independently. Thus, it is unlikely that cotransferred mouse DNA is responsible for the restoration of senescence in the microcell hybrids reported here. In addition, the deletions mapped in the revertants strongly implicate the human fragment of the donor chromosome as responsible for the senescent phenotype. Moreover, whole cell hybrids between A9 cells and rat ovarian and brain tumor cells are invariably immortal (Kaur and Athwal, unpublished data) suggesting that no A9 chromosome can confer senescence in these cells. All senescent MCF.7 microcell hybrids entered growth arrest at approximately the same time, but post-replicative senescent MCF.7 cells carrying an intact normal chromosome 16 remained attached to plates longer than their counterparts carrying fragments (Table 1 ). The reason for this dierence is not known but it could re¯ect a cell line speci®c eect of other co-transferred genes on chromosome 16.
Although this is the ®rst report of a senescence gene on chromosome 16, the existence of tumor suppressor genes on this chromosome has been predicted from classical studies of loss of heterozygosity (LOH) on dierent tumors. In addition to breast carcinoma (Sato et al., 1991; Lindblom et al., 1993; Tsuda et al., 1994) , frequent deletions on 16q have been reported in prostate carcinoma (Latil et al., 1997) , hepatocellular carcinoma (Tsuda et al., 1990) and Wilms tumors (Maw et al., 1992) . The high incidence of allelic losses on 16q, in multiple tumors, suggest a universal role for gene(s) present on 16q in dierent cancers. Three regions on 16q, 16q22.2-16q22.1, 16q23.1-q23.3 and 16q24.3-qter, which show a high incidence of allelic imbalance, have been implicated in pathogenesis of breast cancer (Devilee et al., 1991; Cleton-Jansen et al., 1994; Tsuda et al., 1994; Lida et al., 1997) . However, most frequent LOH has been observed at 16q24.3-qter irrespective of the stage of the disease (reviewed in Brenner and Aldaz, 1997; Tsuda et al., 1994; Devilee and Cornelisse 1994) , suggesting that allelic imbalance at 16q24.3 may be an early event in the progression of breast cancer.
LOH analysis has been useful to identify loci that are deleted in tumor cells. However, it does not dierentiate which loci are directly involved in tumor development and which may be lost coincidentally due to genomic instability associated with the malignant state. In contrast, functional complementation can distinguish whether a locus is involved in the suppression of tumorigenicity and/or metastasis in vivo or inhibition of cell growth and/or restoration of senescence in vitro (reviewed in Oshimura and Barrett, 1997; Goyette et al., 1992) . Our results show that a gene located at 16q24.3 is responsible for limiting the proliferative life span of breast tumor cells.
Several interesting genes, thought to be involved in the regulation of cell growth, have been mapped at 16q24.3. These include the renal dipeptidase gene, DPEP1 (Austruy et al., 1993) ; melanocortin stimulating hormone receptor gene, MCIR (Gantz et al., 1994) ; breast basic conserved gene, BBC1 (Adams et al., 1992) ; adhesion regulatory molecule, CMAR (Pullman and Bodmar, 1992) ; a metallopeptidase gene, PRISM1 (Scott et al., 1996) ; a gene named PISSLRE (Li et al., 1992) ; and the Fanconi Anaemia group A gene, FAA (Pronk et al., 1995) . All these genes have been located within a 960 kb DNA segment mapping between D16S3026 and D16S303 (Whitmore et al., 1998) which is distal to the region deleted in our immortal MX revertants clones. Thus, we have excluded all these genes as candidates for SEN16, based upon their map position or their retention in immortal revertants of senescent microcell hybrids.
The fact that SEN16 had essentially the same eect in four independently derived rat and human tumor cell lines suggests that it complements a common if not universal defect in mammary tumor cells. Since escape from senescence is considered to be involved in the conversion of non-malignant tumors to the malignant state, it is probable, that inactivation of SEN16 may be an essential step during the early stages of tumor progression required for unlimited clonal expansion of the tumor. Direct testing for the role of SEN16 in the regulation of cell proliferation and mammary tumorigenesis will be possible once the gene is cloned.
Materials and methods
Cell lines and growth conditions
Two human breast adenocarcinoma cell lines, SKBR-3 and MCF.7 (American Type Culture Collections, Rockville, MD, USA), and two rat mammary tumor cell lines NMU (American Type Culture Collections), and LA7 (Ehmann et al., 1991) were used as recipients for microcell transfer experiments. Mouse/human monochromosomal hybrid cell lines RA7, RA13A and RA16A, RA16S3 and RA16S2, each carrying a gpt tagged normal human chromosome, were used as donors to transfer 7, 13, 16, 16q22-qter and 16q23-qter, respectively (RS Athwal, unpublished results). The human chromosomes in this panel of mouse/human monochromosomal hybrids came from normal diploid cell line GM03468A (Human Genetic Mutant Repository, Camden NJ, USA).
All cell lines were routinely cultured in DF12 medium supplemented with 10 ± 15% fetal bovine serum at 378C in a 7.5% CO 2 /air atmosphere. The medium for selection and propagation of chromosome transfer clones and donor mouse/human monochromosomal hybrid cell lines contained 25 mg/ml mycophenolic acid and 70 mg/ml xanthine (MX medium).
Microcell mediated chromosome transfer
Micronuclei formation in donor cells was induced by mitotic arrest with colcemid (0.2 mg/ml) for 40 h and microcells were prepared by zonal centrifugation as previously described (Athwal et al., 1985) . Puri®ed microcells were layered on top of a monolayer of recipient cells (2610 6 /10 cc dish) in the presence of phytohemagglutinin-P (PHA-P, 100 mg/ml) and plates were incubated at 378C for 15 min. The cell fusion was facilitated by the addition 1 ml of PEG 1500 (Boehringer Mannheim) using the standard procedure (Athwal et al., 1985) . In each experiment microcells prepared from approximately 2610 7 cells were fused with 4 ± 5610 6 recipient cells. After fusion, cells were cultured in nonselective medium for 24 h, and then transferred to MX medium. Microcell hybrid colonies, observed during the ensuing period of 3 ± 4 weeks, were either isolated individually or maintained in the same plates in MX medium.
Analysis of chromosome transfer clones
Chromosome transfer colonies were maintained in MX medium and examined for cellular and colony morphology and photographed at regular intervals. The population doubling time in each colony was determined by counting cells, either under the microscope or in photomicrographs. The presence or absence of the donor chromosome in each clone and the location of deletions in the donor chromosome were determined by PCR analysis for donor chromosome speci®c DNA markers. All primer pairs for PCR amplification were either purchased from Research Genetics (Huntsville, AL, USA) or synthesized commercially. Chromosome 16 speci®c markers used for mapping included: D16S303, 305, 402, 413, 422, 449, 476, 486, 488, 498, 520, 686, 2621 , 2625 , 2693 , 2727 , 2750 , 2751 , 2772 , 2733 , 2784 , 2790 , 2801 , 2807 , 2866 WI-1435, 1728, 3181, 3217, 3661, 6143, 7624, 8422, 10279, 10391, 11335, 11775, 12410, 13072, 15502, 15838, 16080, 16844, 16952, 17119, 17574, 18220 and 18377; SHGC2485, 2489, 3238 and 11987; StSG 2389 StSG , 2700 SGC30619, 30711, 31012, 32044, 33145, 33289 and 36958; KIAA0182 and 0233; TIGR-A00B17, A001Y24, A00Y26, A008S19, A00Q31 and A002Y45; D42053, D29571, D29107; U06088; X6563; EST00889; PRSM1 and BBC1.
Microcell hybrids of human cells were analysed for polymorphic dinucleotide repeat markers (Dib et al., 1996) to distinguish among donor and recipient cell chromosomes. Brie¯y, the CA strand primers were end labeled with 32 P and used in PCR reactions as described (May and Weber, 1989) . PCR products from chromosome transfer clones and parental cell lines were compared by separation in 6% polyacrylamide denaturing gels to distinguish donor and recipient alleles.
In microcell hybrids derived from rat recipient cells, human donor chromosome markers were detected by conventional PCR ampli®cation. The PCR products were resolved on 2% agarose gels and visualized after staining with ethidium bromide. PCR ampli®cations were performed in a 25 ml reaction volume containing PCR buer, 200 mM dNTPs, 2 mM MgCl 2 and 10 picomoles primer pair, using the conditions as recommended by the primer supplier (Research Genetics, Huntsville, AL, USA).
The gpt gene present on the donor chromosome was detected by PCR ampli®cation of a 700 bp segment using GPT1 and GPT2 primers as described (Kaur and Athwal, 1993) .
Cytogenetic analysis
Metaphase spreads of microcell hybrids were prepared by standard methods and analysed by Fluorescent In Situ Hybridization (FISH). A biotinylated probe prepared from total human DNA was hybridized to metaphase spreads and was detected by staining with¯uorescein labeled streptavidin (Oncor, Gaithersburg, MD, USA) as recommended by the supplier.
